Bioline Receives Clearance for the Commercialization in Australia of the New Molecular Test illumigene® Group B Streptococcus

News   Mar 21, 2012

 
Bioline Receives Clearance for the Commercialization in Australia of the New Molecular Test illumigene® Group B Streptococcus
 
 
 

RELATED ARTICLES

Should Historic Doping Issues Strip All Athletes of World Records?

News

A proposal had been put forward by the European Athletics Council to disregard all world records set before 2005 due to issues with doping. However, a recent publication suggests these plans should be abolished.

READ MORE

Infrared Spectroscopy Test Can Diagnose Two Cancer Types

News

Researchers used mid-infrared spectroscopy to analyze blood serum derived from experimental mice and differentiate mice with non-Hodgkin’s lymphoma and subcutaneous melanoma from healthy mice and also between these two tumorous conditions.

READ MORE

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE